Literature DB >> 4796610

The effect of dantrolene sodium on spasticity in multiple sclerosis.

A J Gelenberg, D C Poskanzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4796610     DOI： 10.1212/wnl.23.12.1313

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Evidence basis for treatment of spasticity.

Authors:  D M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

2.  Comparison of dantrolene sodium and diazepam in the treatment of spasticity.

Authors:  R T Schmidt; R H Lee; R Spehlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

Review 3.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

4.  Effect of dantrolene on KCl- or NMDA-induced intracellular Ca2+ changes and spontaneous Ca2+ oscillation in cultured rat frontal cortical neurons.

Authors:  T Hayashi; A Kagaya; M Takebayashi; T Oyamada; M Inagaki; Y Tawara; N Yokota; J Horiguchi; T P Su; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 6.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

Review 7.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 8.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.